Merck KGaA (ETR:MRK – Get Free Report)’s stock price fell 1.3% on Tuesday . The company traded as low as €155.15 ($172.39) and last traded at €155.55 ($172.83). 414,140 shares traded hands during trading, The stock had previously closed at €157.55 ($175.06).
Merck KGaA Stock Down 1.3 %
The company has a current ratio of 1.31, a quick ratio of 0.72 and a debt-to-equity ratio of 37.56. The company has a market capitalization of $20.10 billion, a P/E ratio of 25.75, a PEG ratio of 2.57 and a beta of 0.71. The firm’s 50 day moving average price is €165.64 and its two-hundred day moving average price is €161.23.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
See Also
- Five stocks we like better than Merck KGaA
- Why Invest in High-Yield Dividend Stocks?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Golden Cross Stocks: Pattern, Examples and Charts
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is a Stock Market Index and How Do You Use Them?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
